Overview

Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this research study is to investigate if the incidence of nausea and vomiting that subjects experience during and after a Cesarean section can be reduced by giving a shot of the drug ephedrine into the thigh muscle at the time of spinal anesthesia administration.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Weill Medical College of Cornell University
Collaborator:
New York Presbyterian Hospital
Treatments:
Ephedrine
Pseudoephedrine
Criteria
Inclusion Criteria:

- Must be pregnant with a single baby

- Must be at term in their pregnancy (estimated gestational age of at least 38 weeks)

- Must be scheduled for an elective Cesarean section

- Must be between 60-70" tall

- Must be free of severe systemic disease (ASA class I or II)

Exclusion Criteria:

- Contraindication to spinal anesthesia

- Any allergy to any of the medications included in the study

- History of pregnancy-induced hypertension or preeclampsia

- History of preexisting hypertension

- Diabetes mellitus

- Hyperemesis gravidum

- Previous perioperative nausea and vomiting

- History of motion sickness

- Women carrying a fetus with a known abnormality will also be excluded from the study